๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

p16 (CDKN2/MTS1) Gene Deletions are Rare in Prostatic Carcinomas in the United States and Japan

โœ Scribed by Mangold, Kathy A.; Takahashi, Hiroyuki; Brandigi, Claus; Wada, Tetsuro; Wakui, Shin; Furusato, Masakuni; Boyd, Jeff; Chandler, Francis W.; Allsbrook, William C.


Book ID
122491453
Publisher
Lippincott Williams and Wilkins
Year
1997
Tongue
English
Weight
538 KB
Volume
157
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Deletional, mutational, and methylation
โœ David F. Jarrard; G. Steven Bova; Charles M. Ewing; Sokhom S. Pin; Son H. Nguyen ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 98 KB ๐Ÿ‘ 1 views

The tumor suppressor gene CDKN2 (p16/MTS1) resides on chromosome 9p21 and encodes a 16 kDa inhibitor of the cyclin-dependent kinases. Inactivation of CDKN2 by homozygous deletion, point mutation, and recently described aberrant methylation in the 5' promoter region may increase progression through t

Frequency of mutation and deletion of th
โœ K Biden; J Young; R Buttenshaw; J Searle; G Cooksley; D B Xu; B Leggett ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 476 KB

The tumor suppressor gene CDKN2A (MTS1/p16), located on chromosome 9p21, is inactivated in a variety of tumors including melanomas and tumors of the biliary tract, pancreas, and stomach. The aim of the present study was to determine whether this gene is inactivated in hepatocellular carcinoma (HCC).